Loading viewer...
investor_presentation
Format: PDF investor_presentation
Repligen is a bioprocessing solutions provider offering differentiated, single-use technologies for biological drug manufacturing. The company reported $671M in 2021 revenue with 45% growth, driven by innovation and market leadership in the expanding biologics sector with an $8B+ TAM.
investor_presentation
11 Pages
investor_presentation
35 Pages
Spur Wechsel
Cabot Microelectronics Investor Presentation — May 2021
investor_presentationinvestor_presentation
16 Pages
Cabot Microelectronics Corporation
